Wearable cues help walking timing
- Trial ID
- NCT06430151
- Official Title
- Useability and Acceptability of the CUE1 Device in Older People With Parkinson's Disease
- Goal
- Wearable cues help walking timing
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Dr Alistair Mackett
- Study Type
- INTERVENTIONAL
- Enrollment
- 20 participants
- Conditions
- Parkinson Disease
- Interventions
- CUE1
Summary For Families
The goal is to find out whether older people with Parkinson's can comfortably use and accept the CUE1 wearable as a help for walking and movement timing. CUE1 is a small, chest-worn adhesive device that delivers gentle tactile cues to help time steps and posture; it is a non-drug, wearable aid so it would be used alongside levodopa rather than interacting with it. The focus is on real-world usability, comfort, and whether people are happy to wear it, not on testing a new medication. They are looking for 20 people aged 60 to 100 with a confirmed Parkinson's diagnosis under the Cambridge movement disorder service, excluding those with dementia or other major neurological diseases, atypical parkinsonism, implanted devices like pacemakers or DBS, chest trauma or adhesive sensitivity, severe mobility-limiting conditions, inability to consent, or current participation in another intervention trial.
Locations
- Cambridge University Hospitals Foundation Trust, Cambridge, United Kingdom
Frequently Asked Questions
- What is this trial testing?
- This trial is studying CUE1. The goal is to find out whether older people with Parkinson's can comfortably use and accept the CUE1 wearable as a help for walking and movement timing. CUE1 is a small, chest-worn adhesive device that delivers gentle tactile cues to help time steps and posture; it is a non-drug, wearable aid so it would be used alongside levodopa rather than interacting with it. The focus is on real-world usability, comfort, and whether people are happy to wear it, not on testing a new medication. They are looking for 20 people aged 60 to 100 with a confirmed Parkinson's diagnosis under the Cambridge movement disorder service, excluding those with dementia or other major neurological diseases, atypical parkinsonism, implanted devices like pacemakers or DBS, chest trauma or adhesive sensitivity, severe mobility-limiting conditions, inability to consent, or current participation in another intervention trial.
- Who can participate?
- Participants must be between 60 Years and 100 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 6 months.
- Will I get the real drug or a placebo?
- It depends on the trial design. Some Parkinson's trials are placebo controlled, meaning a portion of participants get an inactive comparison while others get the experimental treatment. Some use crossover designs so everyone eventually receives the active treatment at some point. Observational trials do not use a placebo at all because they are not testing a new treatment. The consent form for any specific trial spells out the design and your odds of being assigned to placebo before you enroll.
- How often will I need to visit the study site?
- Visit frequency varies by trial. Many Parkinson's studies require an in person visit every 4 to 12 weeks during the active treatment phase, with shorter or longer gaps depending on the design. The site coordinator can give you the full visit schedule before you sign anything, so you know what the time commitment looks like.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Will travel or parking be reimbursed?
- Many trials reimburse for parking, mileage, and sometimes lodging if the site is far from your home. Reimbursement policies vary by sponsor and site. When you contact the trial team, ask specifically what is covered and how reimbursement is processed.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.